Article thumbnail

Plasma IL-6 and IL-10 levels in visceral leishmaniasis (VL) patients during clinical follow up.

By Aline Mireille da Cunha Fievez (6508820), Maria Luciana Silva-Freitas (3372833), Anastácio de Queiroz Sousa (4182556), Joanna R. Santos-Oliveira (214184) and Alda M. Da-Cruz (214196)


<p><b>(A)</b> IL-6 and <b>(C)</b> IL-10 levels were analyzed in the active phase and one-month post-treatment (1 mpt) in VL patients and in healthy volunteers. <b>(B and D)</b> The insert shows the IL-6 and IL-10 levels from the same patients prospectively evaluated in two different time points (n = 22). Each symbol represents one patient. The horizontal bar represents the median values. Asterisks denote a statistically significant difference between groups, *p<0.05; **p<0.01.</p

Topics: Biochemistry, Medicine, Microbiology, Cell Biology, Genetics, Molecular Biology, Neuroscience, Immunology, Developmental Biology, Science Policy, Computational Biology, Physical Sciences not elsewhere classified, macrophage microbicidal mechanisms, leptin levels, decrease VL lethality, SIRS, VL patients, 1 mpt, vivo Leishmania infection models, leishmaniasis patients Visceral leishmaniasis, serum leptin levels, parameter, LPS, IL
Year: 2019
DOI identifier: 10.1371/journal.pone.0214413.g003
OAI identifier:
Provided by: FigShare
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.